Business Development in an Era of Transformative Therapies

July 25, 2019 8:00 AM - 10:00 AM

MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139

Add to Calendar 7/25/2019 8:00:00 AM 7/25/2019 10:00:00 AM Business Development in an Era of Transformative Therapies

The future of therapeutics capable of treating, curing, and even entirely preventing many previously life-threatening illnesses has arrived! Whether it is developing drugs for molecular targets rather than specific diseases, replacing/correcting specific genes, or introducing cells engineered with bespoke features or payloads, a new dawn is upon us. For business development leaders this presents unusual and unprecedented challenges. How do unproven development pathways, uncertain and fluctuating markets sizes, and the potential for value-based pricing and payments affect how deals are negotiated and structured? Join us for a discussion among biopharma business development and finance leaders in this emerging space as they share their thoughts on creating value through business and corporate development activities in the context of the radical new technologies that are changing the practice of medicine.

 MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Chief Business Officer, uniQure
Most recently, Mr. Garen served as Chief Business Officer at Syros Pharmaceuticals, where he was responsible for business transactions including partnering Syros’ technology platform and drug assets, and bringing in products to enhance and accelerate its pipeline. Prior to joining Syros, Mr. Garen was the Assistant Vice President of Business Development at Forest Laboratories from 2003 to 2014, and subsequently, Actavis, plc until 2015 following its acquisition of Forest Laboratories. At Forest Laboratories and Actavis, Mr. Garen was responsible for numerous acquisitions and license agreements to build the companies' pipeline in all its focus therapeutic areas, and led a team of business development professionals. Earlier in his career, Mr. Garen was Director of Global Licensing with Pharmacia Corporation and a Founder and Vice President of Technology Exchange, Inc., in New York, NY. Mr. Garen holds a Master of Environmental Science degree from Yale University and a Bachelor of Science degree in Physics from the Massachusetts Institute of Technology.